Covid-19 can trigger body-wide inflammation that eventually makes its way to the brain, impairing cognitive function. Research suggests that other viral diseases may share the same mechanism of damage.
Population genetic testing is here, and will save lives and money for employers, payers, and our health care system. But first we have to create financial toxicity safeguards for the individuals having these tests, and their family members.
It’s no surprise people say the healthcare system’s pricing is “rigged.” The drug supply chain is riddled with sub-optimal market features, none of which favor the patient. The blame for high drug prices and out-of-pocket spending goes beyond drug make…
A regularly heard talking point is that follow-on drugs, such as biosimilars and generics, will bring down prices through competition. But, they don’t invariably do so. PBMs may favor more expensive branded products over similar or even bioequivalent v…
Imposing rebates on list prices of drugs that exceed inflation, restructuring Medicare Part D (particularly the catastrophic phase of the outpatient drug benefit), and Medicare negotiations for certain drugs, will have a limited impact on the drug indu…
Even mild Covid-19 may worsen cognitive health. How? By triggering a strong inflammatory response that makes its way to the central nervous system, leading to overabundant activation of immune cells in the brain.
FDA may soon approve the first OTC birth control pill in the U.S. And, more novel prescription-to-OTC switches could be on tap. But, the FDA’s proposed plan to facilitate more switches in new therapeutic categories lacks clarity, and it doesn’t include…